[1]
Srushti Chame et al. 2026. A Critical Appraisal of Lc–Ms/Ms Bioanalytical Method Validation for Cilostazol According To USFDA and ICH M10. Asian Journal of Pharmaceutical Research and Development. 14, 2 (Apr. 2026), 138–142. DOI:https://doi.org/10.22270/ajprd.v14i2.1745.